FAQ

Wilate

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
01220112017

Related topics

Related topics

8 relations

Broader (8)

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETEDAntihemophilic Factor, Human RecombinantFactor VIIIantihemophilic factor, porcine B-domain truncated recombinant
(More)

Related mentions per year

Related mentions per year

1947-2018
19401960198020002020
Wilate
von Willebrand factor, human
von Willebrand factor
Factor VIII
Antihemophilic Factor, Human Recombinant
recombinant antihemophilic factor VIII

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy and safety of a VWF/FVIII concentrate (wilate® ) in inherited von Willebrand disease patients undergoing surgical procedures.
INTRODUCTION Surgical procedures in von Willebrand disease (VWD) patients may require prophylactic treatment with exogenous von… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2015
2015
ADAMTS13 content and VWF multimer and triplet structure in commercially available VWF/FVIII concentrates.
ADAMTS13 is a metalloproteinase that cleaves von Willebrand factor (VWF) into smaller multimers in vivo. This cleavage creates… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Utility of a high VWF:FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice
Treatment of von Willebrand disease typically requires multiple infusions of von Willebrand factor (VWF)/factor VIII (FVIII… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.
Treatment with exogenous von Willebrand factor (VWF) is indicated in patients with von Willebrand disease (VWD) in whom treatment… (More)
Is this relevant?
2011
2011
The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover…
The pharmacokinetic (PK) profiles of von Willebrand factor (VWF) /factor VIII (FVIII) concentrates are important for treatment… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2011
2011
Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model.
The ratio of von Willebrand factor (VWF) to FVIII differs among available VWF/FVIII concentrates. Repeated infusions of… (More)
Is this relevant?